Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 6/2000

01-11-2000 | Originales

Carcinoma de nasofaringe localmente avanzado: resultados finales del tratamiento de quimiorradioterapia seguido de quimioterapia complementaria

Authors: Marta Moreno, Esteban Salgado, Ignacio Azinovic, Rosa María Cañón, José María López-Picazo, César Beltrán, Rafael Martínez, Joseba Rebollo, Javier Aristu, Antonio Brugarolas

Published in: Clinical and Translational Oncology | Issue 6/2000

Login to get access
Metadata
Title
Carcinoma de nasofaringe localmente avanzado: resultados finales del tratamiento de quimiorradioterapia seguido de quimioterapia complementaria
Authors
Marta Moreno
Esteban Salgado
Ignacio Azinovic
Rosa María Cañón
José María López-Picazo
César Beltrán
Rafael Martínez
Joseba Rebollo
Javier Aristu
Antonio Brugarolas
Publication date
01-11-2000
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 6/2000
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/BF02979593

Other articles of this Issue 6/2000

Clinical and Translational Oncology 6/2000 Go to the issue

Originales

Small cell lung cancer in the elderly: factors influencing treatment decision and effect on survival

EditorialNotes

Editorial

Originales

Factores pronósticos e indicaciones quirÚrgicas en las metástasis hepáticas de carcinoma colorrectal

Correspondencia

Chemoresistance can limit the success of radical surgery followed by early postoperative intraperitoneal chemotherapy in gastric carcinoma

Originales

Preoperative CA 15.3 and prognosis in primary breast cancer

Revisiones

Matrix metalloproteinases as emerging targets for cancer therapy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits